Thought Leadership

The Clinical Lab Post-COVID-19

As we adjust to a “new normal,” clinical leaders must be prepared to embrace a shift toward hybrid work

Written byDonald Mason, MSc
| 3 min read
A laboratory worker wearing PPE handles automated hematology equipment
Register for free to listen to this article
Listen with Speechify
0:00
3:00

The impact of COVID-19 on clinical laboratories 

Corporate employees weren’t the only ones sent home last March. Scientists in clinical labs across the nation lost time, access to technology, and critical on-site data when COVID-19 numbers spiked. The experience has opened the eyes of many in the life sciences to how, where, and when they can work. 

With a recent survey revealing that 72 percent of respondents think the lab of the future will be 50 percent virtual or more by 2030, it’s important for leaders to recognize the underlying shift toward hybrid work in the life science industry. As we adjust to the “new normal,” clinical leaders must be prepared to embrace the future of science and lab research. 

Advances in innovation

To continue reading this article, sign up for FREE
Today's Clinical Lab Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.
Unlock for FREE
Add Today's Clinical Lab as a preferred source on Google

Add Today's Clinical Lab as a preferred Google source to see more of our trusted coverage.

About the Author

  • Placeholder image
    Donald Mason is the global scientific affairs manager for Waters Corporation’s in vitro diagnostics business. He has 20+ years’ experience in the application of liquid chromatography and mass spectrometry to high-value medical lab tests. Mr. Mason has served on numerous scientific/advisory committees of internationally recognized professional societies including CLSI, AACC, and MSACL.View Full Profile

Related Topics